Home › Blog › Weight Loss › Mounjaro Birmingham
Mounjaro Birmingham 2026: NHS vs Private, Prices From £139, Waiting Times and How to Get Started Today
Get Mounjaro in Birmingham — Delivered Next Day, No Waiting List
GPhC-regulated · NHS-contracted · Fixed 2026 prices · Free monthly check-ins · next-day delivery to all West Midlands postcodes
- ✅ Mounjaro 2.5mg £139.00 · 5mg £165.00 · 7.5mg £225.00 · 10mg £255.00 · 12.5mg £275.00 · 15mg £285.00
- ✅ Wegovy from £99.99 — full escalation range available
- ✅ Free starter pack (needles + sharps bin) · Free monthly check-ins · £4.99 delivery
- ✅ No subscription · No minimum term · GPhC No. 1033729 · NHS-contracted
Mounjaro in Birmingham: The Essential Guide
Mounjaro (tirzepatide) is the UK’s most prescribed weight loss injection — producing an average of 22.5% body weight loss at 15mg over 72 weeks in the landmark SURMOUNT-1 trial. For patients in Birmingham and West Midlands, access comes through two routes: NHS prescription via tier 3 specialist services (with significant waiting times), or private prescription through a GPhC-registered provider like Slinic with next-day delivery.
This guide covers everything a Birmingham patient needs to know: NHS eligibility and waiting times in NHS Birmingham and Solihull ICB / NHS Black Country ICB, how to access private Mounjaro at fixed 2026 prices, eligibility criteria, dosing, and what to expect.
Obesity in Birmingham: The Local Picture
The West Midlands has an obesity rate of approximately 32% — the highest of any English region. Within the region, Birmingham’s inner-city wards and the Black Country towns of Wolverhampton, Dudley, and Walsall have rates exceeding 35% in the most deprived areas. This reflects decades of industrial decline, high unemployment, and a food environment that makes healthy eating disproportionately difficult for many residents.
For Birmingham’s large South Asian community — one of the largest in Europe — ethnic group BMI adjustments are clinically critical. Slinic applies these automatically: BMI 23+ with a qualifying condition qualifies for Mounjaro or Wegovy at Slinic, compared to the standard 27+ threshold.
How to Get Mounjaro in Birmingham: Two Routes
| Route | NHS — via NHS Birmingham and Solihull ICB / NHS Black Country ICB | Private — Slinic |
|---|---|---|
| Eligibility threshold | BMI 35+ with 4 qualifying conditions (phase 2, from June 2026) | BMI 30+ or BMI 27+ with 1 qualifying condition |
| GP referral needed | Yes — tier 3 weight management referral | No — online assessment directly with Slinic |
| Typical waiting time | 18–24 months (among the longest in England) | 24–48 hours from assessment to delivery |
| Cost per pen | £9.90 (standard NHS prescription charge) | £139–£285 depending on dose |
| Clinical monitoring | Multidisciplinary tier 3 team | Free monthly check-ins with Slinic prescriber |
| Free starter pack | Needles and clinical supplies via service | ✅ Yes — needles and sharps bin included |
| Can run simultaneously | ✅ Yes — you can be on the NHS waiting list and access private Mounjaro simultaneously | |
NHS Mounjaro in Birmingham: Current Status and Waiting Times
| ICB | Phase 2 status | Tier 3 wait |
|---|---|---|
| NHS Birmingham and Solihull ICB | Phase 2 rolling from June 2026 | 18–24 months |
| NHS Black Country ICB | Phase 1 active; phase 2 rolling | 18–24 months |
| NHS Coventry and Warwickshire ICB | Phase 1 and 2 active | 15–24 months |
Birmingham and the Black Country face the UK’s most acute NHS weight management access challenge — very high obesity rates combined with NHS service capacity that cannot meet demand. Waiting times of 18–24 months are among the longest in England. The April 2026 Wegovy cardiovascular NICE approval offers a potentially faster GP pathway for patients with CVD and BMI 27+ without T2D.
Private Mounjaro in Birmingham: Slinic’s Fixed 2026 Prices
Slinic delivers MHRA-licensed Mounjaro from Eli Lilly’s authorised UK supply chain to West Midlands next day. Fixed 2026 prices — no subscription, no minimum term, no hidden fees.
| Mounjaro dose | Slinic price (2026 fixed) | Delivery | Monthly total | Treatment stage |
|---|---|---|---|---|
| 2.5mg | £139.00 | £4.99 | £143.99 | Starting dose — initiation (weeks 1–4) |
| 5mg | £165.00 | £4.99 | £169.99 | First therapeutic dose (weeks 5–8) |
| 7.5mg | £225.00 | £4.99 | £229.99 | Mid-escalation (weeks 9–12) |
| 10mg | £255.00 | £4.99 | £259.99 | Upper escalation — 19.5% avg weight loss |
| 12.5mg | £275.00 | £4.99 | £279.99 | High maintenance |
| 15mg | £285.00 | £4.99 | £289.99 | Maximum dose — 22.5% average weight loss |
| Wegovy 0.25mg | £99.99 | £4.99 | £104.98 | Wegovy starting dose |
| Wegovy 2.4mg | £209.99 | £4.99 | £214.98 | Wegovy maintenance — 14.9–20.7% avg weight loss |
Each pen contains 4 weekly doses. Prices verified June 2026. No subscription — order when ready.
Am I Eligible for Mounjaro in Birmingham?
Eligibility for private Mounjaro at Slinic (the route available immediately, without NHS waiting lists) requires:
- BMI 30 or above — no qualifying condition needed
- BMI 27 or above with at least one qualifying condition: type 2 diabetes, hypertension, cardiovascular disease, high cholesterol, sleep apnoea, NAFLD, PCOS, or obesity-related osteoarthritis
- Age 18 or over
- No absolute contraindications — including no personal or family history of medullary thyroid carcinoma or MEN2; not pregnant or breastfeeding
What Slinic Includes for Birmingham Patients
| What’s included | Details |
|---|---|
| Full clinical assessment | Every prescription reviewed by a registered pharmacist prescriber — contraindication screening, drug interaction review, weight verification |
| Free starter pack | Needles and sharps bin included with first order — everything you need to start |
| Free monthly check-ins | Structured clinical review every month — weight progress, dose management, side effect support, nutritional guidance |
| Cold-chain delivery to West Midlands | Certified cold-chain packaging · Next-day tracked delivery · next-day delivery to all West Midlands postcodes |
| No subscription | Order when ready — no automatic billing, no minimum term, no cancellation fee |
| SCOPE Obesity accreditation | Slinic is specifically accredited for obesity clinical care — not just a general prescribing service |
| NHS contract | Slinic holds an NHS contract — the same governance standard as NHS pharmacies |
| LegitScript certification | International standard verifying online pharmacy legitimacy — used by Google and regulators |
The NHS Bridge Strategy for Birmingham Patients
For patients in Birmingham who are on the NHS waiting list (or want to get on it) while also wanting to start treatment now, the bridge strategy makes clinical sense:
- Ask your GP today for a tier 3 weight management referral — this starts the NHS clock
- Start Mounjaro privately at Slinic — your medication arrives in 24–48 hours, you begin losing weight while you wait
- When your NHS tier 3 place comes through (typically 12–24 (among the longest in England)+ months in Birmingham) — transition to NHS supply, typically at the same dose you’re already on
Starting private treatment does not affect your NHS eligibility or waiting list position. Your Slinic clinician can provide a treatment summary for your NHS tier 3 team when the time comes. See our full NHS Mounjaro guide for more detail →
Start Mounjaro in Birmingham Today — Delivered Tomorrow
Same MHRA-licensed Mounjaro as the NHS · Fixed 2026 prices · NHS-contracted · No waiting list
- ✅ Mounjaro from £139.00 — 22.5% average weight loss at 15mg
- ✅ Wegovy from £99.99 — cardiovascular benefit label (NICE April 2026)
- ✅ Free monthly check-ins · Free starter pack · next-day delivery to all West Midlands postcodes
- ✅ GPhC No. 1033729 · NHS-contracted · SCOPE Obesity Accredited · LegitScript Certified
Mounjaro vs Wegovy for Birmingham Patients
| Factor | Mounjaro (tirzepatide) | Wegovy (semaglutide) |
|---|---|---|
| Average weight loss | 22.5% (15mg, SURMOUNT-1) | 14.9–20.7% (STEP 1 / STEP UP) |
| Mechanism | Dual GLP-1 + GIP agonist | GLP-1 agonist only |
| Cardiovascular benefit label | Not yet — SURPASS-CVOT pending | ✅ NICE approved April 2026 (BMI 27+ with CVD, no T2D) |
| Slinic starting price | £139.00/pen | £99.99/pen |
| Oral option | Not yet available | ✅ Wegovy pill — MHRA approved 11 June 2026 |
| NHS availability (Birmingham) | Via tier 3 (18–24 months (among the longest in England)) | Via tier 3 (18–24 months (among the longest in England)) or GP cardiovascular pathway |
| Head-to-head trial (SURMOUNT-5) | 20.2% weight loss | 13.7% weight loss |
How to Get Started at Slinic — Birmingham Patients
- Complete the free 2-minute eligibility assessment at slinic.co.uk/consultation
- A registered Slinic prescriber reviews your assessment — typically within a few hours during working hours
- If approved, your first Mounjaro or Wegovy pen is dispatched within 24 hours — cold-chain tracked delivery to your Birmingham address
- Your free monthly check-in is scheduled — weight progress, dose management, side effect review, all included
Frequently Asked Questions — Mounjaro in Birmingham
Who Prescribes Mounjaro in Birmingham — What to Verify Before Ordering
Searching “Mounjaro Birmingham” returns many providers. With NHS waiting times of 18–24 months across the West Midlands, demand for private providers is intense — and that creates risk. Here is exactly what to verify before ordering Mounjaro from any provider in the West Midlands:
| What to check | Why it matters | Slinic status |
|---|---|---|
| GPhC registration | Legal requirement to dispense Mounjaro in the UK. Verify at pharmacyregulation.org. If a provider cannot give you their GPhC number, do not order from them. | ✅ GPhC No. 1033729 |
| NHS contract | NHS-contracted pharmacies operate under NHS governance and audit standards — the gold standard for clinical governance in UK pharmacy. | ✅ Yes |
| SCOPE Obesity accreditation | Specialist obesity clinical standard — confirms the team has been specifically assessed in obesity management, not just general prescribing. | ✅ Yes |
| LegitScript certification | International online pharmacy verification. Used by Google and regulators to identify legitimate providers versus unlicensed sellers. | ✅ Yes |
| Registered UK prescriber review | Every Mounjaro prescription must be reviewed by a GMC, GPhC, or NMC registered prescriber. Not an algorithm or automated system. | ✅ Every prescription reviewed by Shadeia Younis or her clinical team |
| Eli Lilly authorised supply | Must be MHRA-licensed Mounjaro from Eli Lilly’s authorised UK supply chain. The MHRA seized 20 million counterfeit weight loss injection doses worth £45M in 2025 — counterfeit pens are a documented and serious risk. | ✅ Eli Lilly authorised supply only |
| Independent weight verification | Required under GPhC February 2025 guidance. Providers who skip weight verification are non-compliant with GPhC guidance. | ✅ Required at every assessment |
What Mounjaro Results Look Like for West Midlands Patients
The SURMOUNT-1 trial recruited 2,539 patients across multiple countries. Here is what the data means for a typical Birmingham or West Midlands patient starting at 100kg:
| Timepoint | Average % loss (15mg) | Real weight (100kg patient) | What patients typically experience |
|---|---|---|---|
| Week 4 (Month 1) | ~3–4% | ~3–4 kg | Food noise quieter. Portions reducing naturally. Scale beginning to move. |
| Week 12 (Month 3) | ~8–9% | ~8–9 kg | Clothes fitting differently. Others beginning to notice. Joints feeling the benefit — significant for many Birmingham patients with obesity-related osteoarthritis. |
| Week 24 (Month 6) | ~14–15% | ~14–15 kg | Major physical transformation. Blood pressure, blood sugar, and lipids all typically improved. Physical activity significantly easier. |
| Week 52 (Month 12) | ~20–21% | ~20–21 kg | Health transformation. Most patients report improved mood, energy, mobility, and self-confidence alongside the metabolic improvements. |
| Week 72 (Month 18) | 22.5% | ~22.5 kg | Full trial result. 57% of patients at 15mg achieved 20%+ weight loss. Rate slows in final months — completely normal and expected. |
The NHS Access Problem in the West Midlands — In Detail
The West Midlands faces the most acute NHS weight management access challenge of any English region. Understanding why helps patients make the right decisions about private treatment:
Why waits are so long
- Highest regional obesity rate — approximately 32% of West Midlands adults are living with obesity, the highest of any English region. Demand for weight management services is proportionally higher.
- High deprivation — Birmingham, Wolverhampton, Walsall, and Sandwell are among the most deprived local authority areas in England. Higher deprivation correlates with higher obesity severity and more complex clinical presentations requiring longer assessments.
- Underfunded tier 3 services — NHS tier 3 weight management services in the West Midlands have not been historically well-funded relative to need. Service capacity has not kept pace with demand even as obesity rates have increased.
- Phase 2 rollout pressure — from June 2026, the phase 2 expansion of NHS Mounjaro prescribing (BMI 35+ with 4 conditions) significantly increases the eligible population. Service capacity is being expanded — but not quickly enough to reduce waiting times immediately.
What patients can do
Patients who are eligible for NHS Mounjaro should get on the waiting list — but should not wait to start treatment. The two routes can run simultaneously:
- Ask your GP for a tier 3 weight management referral today — this starts the NHS clock
- Start private Mounjaro at Slinic immediately — 24–48 hours from assessment to delivery
- When your NHS tier 3 appointment comes (18–24 months in most of the West Midlands) — transition to NHS supply at the same dose
Eligibility for Mounjaro in Birmingham: Private Route (Slinic)
Slinic’s eligibility criteria for private Mounjaro prescribing follow the MHRA licence and GPhC guidance:
| Route | BMI | Conditions needed | Qualifying conditions |
|---|---|---|---|
| Standard — no condition needed | BMI 30+ | None | BMI alone qualifies at 30 or above |
| With qualifying condition | BMI 27–29.9 | At least 1 | Type 2 diabetes · Hypertension · Cardiovascular disease · High cholesterol · Sleep apnoea · NAFLD · PCOS · Obesity-related osteoarthritis |
| Ethnic group adjustment (South Asian, Black African/Caribbean, Chinese, Middle Eastern) | BMI 27.5+ without condition | BMI 23+ with 1 condition | Same as above — significantly expands eligibility for Birmingham’s diverse communities |
Ethnic group adjustments — critical for Birmingham
Birmingham has one of the largest South Asian communities in Europe — with substantial Pakistani, Indian, and Bangladeshi populations particularly in Sparkhill, Bordesley Green, Handsworth, Alum Rock, Moseley, and Lozells. For these communities, the standard BMI thresholds significantly underestimate metabolic risk:
- South Asians develop type 2 diabetes at BMI levels 5–7 kg/m² lower than white European populations
- Cardiovascular risk is elevated at lower BMI in South Asian populations
- NHS England and NICE both endorse lower BMI thresholds for South Asian, Chinese, Middle Eastern, and Black African/Caribbean patients
At Slinic, these adjustments are applied automatically. A Birmingham patient of Pakistani background with BMI 24 and hypertension qualifies for Mounjaro — whereas the standard threshold would require BMI 27+. Mention your background at the assessment and our prescribers apply the correct criteria.
Mounjaro vs Other Weight Loss Options in the West Midlands
| Option | Average weight loss | NHS availability in Birmingham | Private cost |
|---|---|---|---|
| NHS lifestyle services (tier 1 and 2) | 3–5% | Available — no significant wait | Free |
| Orlistat | 3–5% | NHS prescription from GP | £9.90 NHS / £20–40/month OTC |
| Saxenda (liraglutide) | 5–7% | Tier 3 — 18–24 month wait | ~£100–180/month private |
| Wegovy (semaglutide) | 14.9–20.7% | Tier 3 — 18–24 month wait in Birmingham | From £99.99 at Slinic |
| Mounjaro (tirzepatide) | 22.5% | Tier 3 — 18–24 month wait in Birmingham | From £139 at Slinic |
| Gastric band | 14–17% | NHS BMI 40+ — very long wait | £5,000–£8,000 at Birmingham private hospitals |
| Gastric sleeve | 20–25% | NHS BMI 40+ — very long wait | £8,000–£12,000 at Birmingham private hospitals |
| Gastric bypass | 25–35% | NHS BMI 40+, complex criteria | £10,000–£15,000 at Birmingham private hospitals |
Mounjaro achieves weight loss results comparable to gastric sleeve surgery — without the perioperative mortality risk (0.1–0.3%), without general anaesthesia, without hospital admission, without irreversible anatomical changes, and at £139–£285/month versus £8,000–£12,000 total for surgery.
The April 2026 Wegovy Cardiovascular Pathway: Particularly Relevant for Birmingham
Birmingham has significantly elevated rates of cardiovascular disease compared to the national average — particularly in South Asian communities where risk of coronary heart disease is 50% higher than white European populations, and in areas of high deprivation where rates of hypertension, stroke, and heart failure are substantially elevated.
The April 2026 NICE approval of Wegovy for cardiovascular prevention is therefore particularly significant for Birmingham and West Midlands patients:
| Criteria | Detail | Birmingham relevance |
|---|---|---|
| BMI requirement | BMI 27 or above | Much lower threshold than obesity pathway — more Birmingham patients qualify |
| Cardiovascular condition | Established CVD: prior MI, stroke, peripheral arterial disease, or heart failure | High CVD burden in Birmingham means many patients meet this criterion |
| T2D exclusion | Must NOT have type 2 diabetes | For Birmingham’s many patients with T2D, Mounjaro via the obesity/T2D pathway is the appropriate route |
| NHS access route | GP direct prescription — no tier 3 referral needed | Faster than the 18–24 month tier 3 obesity pathway |
| Private access now | Wegovy from £99.99 at Slinic | Available immediately — no wait |
If you have established cardiovascular disease, BMI 27+, and no type 2 diabetes, ask your GP about the cardiovascular Wegovy pathway — it may be available significantly faster than the tier 3 obesity pathway for Birmingham patients.
Mounjaro Dosing Schedule for Birmingham Patients
| Month | Dose | Slinic price | What to expect |
|---|---|---|---|
| Month 1 | 2.5mg | £139.00 | Starting dose — body adaptation. Appetite begins to reduce. Modest weight loss (1–2 kg). Side effects typically mild at this dose. |
| Month 2 | 5mg | £165.00 | First therapeutic dose. Appetite suppression significantly stronger. Weight loss accelerating. Brief GI side effects typical with dose increase. |
| Month 3 | 7.5mg | £225.00 | Mid-escalation. Visible transformation typically beginning. Cumulative loss ~6–10 kg for most patients. |
| Month 4 | 10mg | £255.00 | High efficacy dose. 19.5% average weight loss in trials at this dose. Many patients find 10mg their optimal maintenance level. |
| Month 5 | 12.5mg | £275.00 | Near-maximum efficacy. Well tolerated by most patients reaching this stage. |
| Month 6+ | 15mg | £285.00 | Maximum dose. 22.5% average weight loss at 72 weeks. Rate slows as body approaches new equilibrium — normal and expected, not a reason to stop. |
Mounjaro Side Effects: What Birmingham Patients Should Know
| Side effect | Rate at 15mg | When it occurs | Practical management |
|---|---|---|---|
| Nausea | ~32% | First 2–4 weeks at each new dose | Eat smaller portions more frequently. Avoid high-fat foods. Eat slowly and stop when satisfied. Contact Slinic if severe — antiemetics can be prescribed. |
| Diarrhoea | ~23% | First 2–4 weeks at each dose | Dietary adjustment. Increase hydration. Reduce high-fibre foods temporarily. Seek review if persistent or severe. |
| Constipation | ~17% | Variable onset | Increase fluid and fibre intake. Macrogol sachets (Laxido or Movicol, available from pharmacies) if needed. Raise at monthly check-in. |
| Vomiting | ~11% | First 2–4 weeks at each dose | Dietary modification. Contact Slinic urgently if unable to keep fluid down for 24+ hours — dehydration risk. |
| Injection site reactions | ~7% | Immediately after injection | Rotate sites — abdomen, thighs, upper arms. Allow pen to reach room temperature before injecting. Avoid the same site consecutively. |
| Hair thinning | Common with rapid weight loss by any method | Months 3–6 typically | Increase protein intake to 1.2–1.6g/kg target body weight. Check ferritin. Does not require stopping medication. |
Mounjaro for Birmingham Patients with Type 2 Diabetes
The West Midlands has significantly elevated rates of type 2 diabetes compared to the national average — particularly in Birmingham’s South Asian communities, where T2D prevalence is 3–6 times higher than in white European populations at equivalent BMI levels. For Birmingham patients with T2D, Mounjaro offers unique advantages:
- Dual licence — Mounjaro is the only weight loss medication in the UK licensed for both weight management AND type 2 diabetes management
- Blood sugar control — SURPASS-2 trial showed Mounjaro 15mg reduced HbA1c by an average of 2.58% — exceptional glycaemic control alongside weight loss
- QOF pathway — the April 2026 QOF update means some Birmingham GP practices can now include Mounjaro within their T2D prescribing pathway, without the 18–24 month tier 3 wait. Ask your GP whether their practice participates
- Medication coordination — if you are already on insulin or sulphonylureas, these doses may need reducing as blood sugar improves with Mounjaro. Coordinate with your GP or diabetes team throughout treatment
How Slinic Delivers to Birmingham and the West Midlands
Slinic dispatches all orders within 24 hours of prescription approval, via next-day tracked cold-chain courier. Deliveries reach all West Midlands postcodes including:
- Birmingham (B1–B45) — all areas including city centre, Solihull, Sutton Coldfield, Edgbaston, Handsworth, Sparkhill, Moseley, and all outer Birmingham postcodes
- Wolverhampton (WV1–WV14)
- Dudley (DY1–DY9)
- Sandwell (B64–B71)
- Walsall (WS1–WS12)
- Coventry (CV1–CV8)
- Solihull (B90–B95)
Cold-chain packaging maintains 2–8°C throughout transit — critical for Mounjaro’s stability. Slinic uses specialist pharmaceutical cold-chain couriers, not standard parcel services. In summer months when ambient temperatures in Birmingham can exceed 25°C, cold-chain packaging ensures your medication arrives at the correct temperature regardless of delivery conditions.
References and Further Reading
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). NEJM, 2022.
- NICE TA1026 — Tirzepatide for managing overweight and obesity. 2025. nice.org.uk/guidance/ta1026
- NICE TA875 — Semaglutide for managing overweight and obesity. 2023.
- NHS Birmingham and Solihull ICB / NHS Black Country ICB. NHS commissioning guidance for weight management medications. June 2026.
- GPhC. Guidance for registered pharmacies providing services at a distance. February 2025. pharmacyregulation.org
- Health Survey for England 2024 / Scottish Health Survey 2024. Adult obesity statistics.
Related Guides
TreatmentOrder Wegovy at Slinic — From £99.99
GuideMounjaro NHS 2026: QOF Update
GuideMounjaro Eligibility UK: Full Criteria
BlogCheapest Mounjaro UK 2026
BlogMounjaro Before and After UK
